Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Assets Average (2016 - 2025)

Historic Assets Average for Cytosorbents (CTSO) over the last 14 years, with Q3 2025 value amounting to $46.9 million.

  • Cytosorbents' Assets Average fell 739.97% to $46.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.9 million, marking a year-over-year decrease of 739.97%. This contributed to the annual value of $50.2 million for FY2024, which is 1364.99% down from last year.
  • Latest data reveals that Cytosorbents reported Assets Average of $46.9 million as of Q3 2025, which was down 739.97% from $49.4 million recorded in Q2 2025.
  • Over the past 5 years, Cytosorbents' Assets Average peaked at $96.6 million during Q3 2021, and registered a low of $46.9 million during Q3 2025.
  • For the 5-year period, Cytosorbents' Assets Average averaged around $64.4 million, with its median value being $55.0 million (2023).
  • As far as peak fluctuations go, Cytosorbents' Assets Average soared by 14777.54% in 2021, and later plummeted by 3200.97% in 2022.
  • Over the past 5 years, Cytosorbents' Assets Average (Quarter) stood at $92.3 million in 2021, then crashed by 32.01% to $62.8 million in 2022, then dropped by 19.9% to $50.3 million in 2023, then dropped by 5.33% to $47.6 million in 2024, then decreased by 1.51% to $46.9 million in 2025.
  • Its last three reported values are $46.9 million in Q3 2025, $49.4 million for Q2 2025, and $49.1 million during Q1 2025.